iBRD4-BD1 (diTFA)
Product Specifications
UNSPSC Description
Target Antigen
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ibrd4-bd1-ditfa.html
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
FC(F)(C1=CC=C(C2=C(C3=CC=NC(OC4=CC(C(C)C)=CC=C4C)=N3)N(C5CCNCC5)C=N2)C=C1)F.OC(C(F)(F)F)=O.OC(C(F)(F)F)=O
Molecular Weight
749.62
References & Citations
[1]Anand Divakaran, et al. Development of an N-Terminal BRD4 Bromodomain-Targeted Degrader. ACS Med Chem Lett. 2022 Sep 29;13(10):1621-1627.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-151594A/iBRD4-BD1-diTFA-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-151594A/iBRD4-BD1-diTFA-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2839318-20-4
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PPP2CA, ID (PPP2CA, Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform, Replication protein C) (MaxLight 750)
PPP2CA, ID (PPP2CA, Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform, Replication protein C) (MaxLight 750)
![Rabbit Polyclonal PARG1 Antibody [Alexa Fluor 647]](https://cdn.genprice.uk/genprice/genprice2.png)